A Better Way To Measure Cognitive Safety And Tolerability


Join ERT and Cogstate for a discussion on how sponsors can use digital cognitive assessments and patient reports to not only increase trial efficiencies but gain more comprehensive insights into their patients’ conditions.

This webinar offers an interactive forum for attendees to engage with experts in the fields of cognitive assessment and clinical research to discuss:

  • The value of assessing cognitive safety and tolerability throughout the drug development process
  • Current relevant regulatory guidance
  • How data from objective performance-based assessments can be integrated with other sources of information to inform trial decision-making
  • Key considerations for selecting and optimizing computerized cognitive assessments  
  • Lessons learned from global cognitive safety studies in various therapeutic areas

Be part of the discussion. Join us on Wednesday, July 29 at 11 AM EST/4 PM BST


FEATURED GUEST


Ken Faulkner

Vice President, Clinical Science & Consulting
ERT

Chris Edgar

Senior Vice President, Clinical Science
Cogstate